Reply to Farkouh RA et al. Comment on “Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children”

Detalles Bibliográficos
Autores principales: Shiragami, Makoto, Mizukami, Akiko, Leeuwenkamp, Oscar, Mrkvan, Tomas, Delgleize, Emmanuelle, Kurono, Yuichi, Iwata, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471061/
https://www.ncbi.nlm.nih.gov/pubmed/25908482
http://dx.doi.org/10.1007/s40121-015-0062-1
_version_ 1782376839171276800
author Shiragami, Makoto
Mizukami, Akiko
Leeuwenkamp, Oscar
Mrkvan, Tomas
Delgleize, Emmanuelle
Kurono, Yuichi
Iwata, Satoshi
author_facet Shiragami, Makoto
Mizukami, Akiko
Leeuwenkamp, Oscar
Mrkvan, Tomas
Delgleize, Emmanuelle
Kurono, Yuichi
Iwata, Satoshi
author_sort Shiragami, Makoto
collection PubMed
description
format Online
Article
Text
id pubmed-4471061
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-44710612015-06-18 Reply to Farkouh RA et al. Comment on “Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children” Shiragami, Makoto Mizukami, Akiko Leeuwenkamp, Oscar Mrkvan, Tomas Delgleize, Emmanuelle Kurono, Yuichi Iwata, Satoshi Infect Dis Ther Letter to the Editor Springer Healthcare 2015-04-24 2015-06 /pmc/articles/PMC4471061/ /pubmed/25908482 http://dx.doi.org/10.1007/s40121-015-0062-1 Text en © The Author(s) 2015 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Letter to the Editor
Shiragami, Makoto
Mizukami, Akiko
Leeuwenkamp, Oscar
Mrkvan, Tomas
Delgleize, Emmanuelle
Kurono, Yuichi
Iwata, Satoshi
Reply to Farkouh RA et al. Comment on “Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children”
title Reply to Farkouh RA et al. Comment on “Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children”
title_full Reply to Farkouh RA et al. Comment on “Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children”
title_fullStr Reply to Farkouh RA et al. Comment on “Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children”
title_full_unstemmed Reply to Farkouh RA et al. Comment on “Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children”
title_short Reply to Farkouh RA et al. Comment on “Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children”
title_sort reply to farkouh ra et al. comment on “cost-effectiveness evaluation of the 10-valent pneumococcal non-typeable haemophilus influenzae protein d conjugate vaccine and 13-valent pneumococcal vaccine in japanese children”
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471061/
https://www.ncbi.nlm.nih.gov/pubmed/25908482
http://dx.doi.org/10.1007/s40121-015-0062-1
work_keys_str_mv AT shiragamimakoto replytofarkouhraetalcommentoncosteffectivenessevaluationofthe10valentpneumococcalnontypeablehaemophilusinfluenzaeproteindconjugatevaccineand13valentpneumococcalvaccineinjapanesechildren
AT mizukamiakiko replytofarkouhraetalcommentoncosteffectivenessevaluationofthe10valentpneumococcalnontypeablehaemophilusinfluenzaeproteindconjugatevaccineand13valentpneumococcalvaccineinjapanesechildren
AT leeuwenkamposcar replytofarkouhraetalcommentoncosteffectivenessevaluationofthe10valentpneumococcalnontypeablehaemophilusinfluenzaeproteindconjugatevaccineand13valentpneumococcalvaccineinjapanesechildren
AT mrkvantomas replytofarkouhraetalcommentoncosteffectivenessevaluationofthe10valentpneumococcalnontypeablehaemophilusinfluenzaeproteindconjugatevaccineand13valentpneumococcalvaccineinjapanesechildren
AT delgleizeemmanuelle replytofarkouhraetalcommentoncosteffectivenessevaluationofthe10valentpneumococcalnontypeablehaemophilusinfluenzaeproteindconjugatevaccineand13valentpneumococcalvaccineinjapanesechildren
AT kuronoyuichi replytofarkouhraetalcommentoncosteffectivenessevaluationofthe10valentpneumococcalnontypeablehaemophilusinfluenzaeproteindconjugatevaccineand13valentpneumococcalvaccineinjapanesechildren
AT iwatasatoshi replytofarkouhraetalcommentoncosteffectivenessevaluationofthe10valentpneumococcalnontypeablehaemophilusinfluenzaeproteindconjugatevaccineand13valentpneumococcalvaccineinjapanesechildren

Ejemplares similares